Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Endocrine 1

Conditions

Motor Activity 5Fatigue 3Breast Neoplasms 3Neoplasms 2Rectal Neoplasms 1Prostatic Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Colorectal Neoplasms 1Colonic Neoplasms 1Asthenia 1Arthritis 1Arthralgia 1

Interventions

Docetaxel 292Prednisone 240enzalutamide 193Leuprolide 185Radiotherapy 179Abiraterone Acetate 169Magnetic Resonance Spectroscopy 163bicalutamide 141Goserelin 138Androgen Antagonists 121acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108Radiosurgery 108apalutamide 92gallium 68 PSMA-11 81abiraterone 81Specimen Handling 73darolutamide 65Surveys and Questionnaires 64Gonadotropin-Releasing Hormone 63Triptorelin Pamoate 58Radiation 57Biopsy 57Brachytherapy 54cabazitaxel 52Standard of Care 51Radiotherapy, Intensity-Modulated 51Zoledronic Acid 50pembrolizumab 49luprolide acetate gel depot 49Flutamide 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × methyl hydroxyethyl cellulose × Clear all
NCT02139774 2015-12-04

Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer

UNC Lineberger Comprehensive Cancer Center

Terminated
15 enrolled
EndocrineGenitourinary

Arthritis, Motor Activity, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡